Study guide

Postoperative inflammation, haemorrhage and PCO

European Board of Ophthalmology Diploma EBOD

Track your progress as you read

Finished sections get a check mark.

1 Chapter 1: EBOD Examination, Applications and Regulations

EBOD Format, Scoring and Revision Planning Eligibility, Applications and the Diploma Online Rules, Technical Preparation and Appeals

2 Chapter 2: Physical Optics, Photometry and Lenses

Light, refraction and total internal reflection Photometry, contrast, colour and adaptation Prisms, decentration and vector combination Vergence, astigmatic lenses and Sturm’s conoid

3 Chapter 3: Instrument Optics, Aberrations and Laser Physics

Cross-cylinder and diagnostic instrument optics Aberrations, duochrome and wavefront analysis Diffraction, polarization, lasers and OCT

4 Chapter 4: Refraction, Accommodation and Spectacle Prescribing

Objective and cycloplegic refraction Subjective refraction and binocular balance Accommodation, presbyopia and vertex distance Spectacle Materials, Measurement and Progressive Lenses

5 Chapter 5: Contact Lenses and Low-Vision Rehabilitation

Contact-lens optics, materials and tear lenses Contact-lens fit and complications Low-vision assessment and magnification Low-vision aids, calculations and ergonomics

6 Chapter 6: Extraocular Anatomy and Motor Physiology

Extraocular muscle anatomy and innervation Eye axes, kinematics and muscle actions Motor laws and orbital pulleys

7 Chapter 7: Binocular Vision and Amblyopia

Binocular vision, stereopsis and the horopter Suppression, correspondence and microtropia Sensory tests and amblyopia treatment

8 Chapter 8: Childhood Assessment and Strabismus Testing

Visual Development, Childhood Testing and Developmental Delay History, corneal reflexes and cover tests Motility patterns, three-step testing and Hess charts

9 Chapter 9: Esotropia, Exotropia and Vertical Deviations

Infantile and accommodative esotropia Exotropia classification and management Vertical Deviations, A–V Patterns and Skew

10 Chapter 10: Dysinnervation, Nystagmus and Muscle Surgery

Duane syndrome, Brown syndrome and restriction Nystagmus patterns and investigation Nystagmus and muscle surgery principles

11 Chapter 11: ROP and Paediatric Ocular Disease

Retinopathy of Prematurity: Screening, Classification and Follow-up Childhood Cataract, Leukocoria and Congenital Glaucoma Childhood Systemic Disease, Infection and Safeguarding

12 Chapter 12: Ocular Surface Anatomy and Infection

Corneal, Conjunctival and Scleral Structure: Examination and Sampling Bacterial keratitis, sampling and treatment Fungal, amoebic and herpetic keratitis Infectious, chlamydial and neonatal conjunctivitis

13 Chapter 13: Allergy, Cicatrisation and Surface Inflammation

Allergic eye disease, trachoma and phlyctenules Cicatrising Conjunctivitis: Mucous Membrane Pemphigoid and SJS/TEN Dry eye, blepharitis and meibomian dysfunction PUK, interstitial keratitis and scleritis

14 Chapter 14: Anterior Segment Dysgenesis and Corneal Dystrophies

Anterior Segment Dysgenesis, Aniridia and Congenital Corneal Opacity IC3D and epithelial or Bowman-layer dystrophies Stromal corneal dystrophies Endothelial corneal dystrophies

15 Chapter 15: Corneal Degeneration, Ectasia and Epithelial Failure

Corneal Degenerations, Pterygium, Band Keratopathy and Dellen Keratoconus and clinical ectasia signs Ectasia imaging, cross-linking and rehabilitation Recurrent Erosion, Neurotrophic Keratopathy and Vitamin A Deficiency

16 Chapter 16: Surface Reconstruction and Keratoplasty

Limbal Stem-Cell Failure, Tarsorrhaphy and Phototherapeutic Keratectomy PK, DALK and endothelial keratoplasty Corneal graft immunity and rejection recognition Graft rejection treatment and postoperative problems

17 Chapter 17: Lens Development, Cataract Assessment and Biometry

Lens Development, Congenital Shape and Ectopia Lentis Lens anatomy and age-related cataract phenotypes Cataract grading, secondary causes and childhood disease Optical and ultrasound biometry

18 Chapter 18: IOL Planning and Phacoemulsification

Keratometry and IOL power formulae Post-refractive biometry, toric alignment and IOL design Phaco fluidics and ultrasound delivery Wounds, OVDs and nucleus techniques

19 Chapter 19: Cataract Anaesthesia and Surgical Complications

Cataract Anaesthesia, Alternative Extraction and Combined Procedures IFIS, capsule rupture and compromised support Postoperative inflammation, haemorrhage and PCO

20 Chapter 20: Corneal and Intraocular Refractive Surgery

Excimer ablation, PRK and LASIK SMILE, surgical selection and complications Phakic IOLs and refractive lens exchange

21 Chapter 21: Presbyopia Procedures and Surface Therapeutics

Presbyopia Surgery, Monovision and Historical Refractive Procedures Surface antimicrobial and anti-inflammatory pharmacology Surface healing, amnion and cenegermin

22 Chapter 22: Aqueous Dynamics, Tonometry and Gonioscopy

Ciliary body and aqueous secretion Outflow and the Goldmann pressure model Tonometry, corneal thickness and biomechanics Gonioscopy optics, landmarks and indentation

23 Chapter 23: Angle, Disc and Visual-Field Assessment

Angle grading and anterior-segment imaging Optic-disc examination and documentation OCT and automated perimetry

24 Chapter 24: Glaucoma Progression, Suspects and Secondary Mechanisms

Field reliability and progression Ocular hypertension, suspects and juvenile glaucoma Lens-related glaucoma, aqueous misdirection and venous pressure

25 Chapter 25: POAG, Angle Closure and Pigmentary Disease

POAG, target pressure and normal-tension disease Angle-closure classification and mechanisms Acute angle closure, iridotomy and lens extraction Pseudoexfoliation and pigmentary glaucoma

26 Chapter 26: Glaucoma Medical, Laser and Surgical Treatment

Neovascular, uveitic and steroid-response glaucoma Glaucoma medicines, SLT and MIGS Trabeculectomy and drainage implants Nonpenetrating surgery, cyclodestruction and postoperative lasers

27 Chapter 27: Retinal Imaging, Diabetes and Vascular Occlusion

Retinal anatomy, examination and multimodal imaging Diabetic microangiopathy and NPDR classification PDR, macular oedema and diabetic trials Retinal vein and artery occlusions

28 Chapter 28: Uncommon Vascular Disease and Myopic Maculopathy

Macroaneurysm, sickle retinopathy and retinal periphlebitis Coats disease and leukocoria assessment MacTel and radiation retinopathy Myopic maculopathy and presumed ocular histoplasmosis

29 Chapter 29: Inherited Retina and Electrophysiology

Retinitis pigmentosa and inherited degeneration Stargardt, Best disease and retinal electrophysiology Cone disorders, stationary night blindness and syndromic retina

30 Chapter 30: AMD, Geographic Atrophy and Pachychoroid

AMD biology and clinical staging Drusen, geographic atrophy and neovascular phenotypes Neovascular AMD trials and treatment CSCR and the pachychoroid spectrum

31 Chapter 31: Retinal Breaks and Detachment Repair

PVD, peripheral degenerations and retinal breaks RRD localization and retinoschisis Detachment mechanisms, pneumatic retinopexy and scleral buckling

32 Chapter 32: Vitrectomy, Macular Surgery and Retinal Trauma

Vitrectomy and intraocular tamponades ERM, macular holes and PVR Retinal trauma, optic-disc pits and choroidal detachment

33 Chapter 33: Uveitis Classification and Non-Infectious Inflammation

SUN classification, grading and uveitis work-up Anterior and intermediate uveitis patterns HLA-B27, sarcoidosis, Behçet disease and VKH Posterior inflammatory patterns and immunomodulation

34 Chapter 34: Infectious Uveitis and Endophthalmitis

Toxoplasmosis and herpetic necrotizing retinitis Ocular syphilis and tuberculosis Immunosuppressed retinitis, toxocariasis and neuroretinitis Endophthalmitis diagnosis and treatment

35 Chapter 35: Optic Neuritis and Ischaemic Optic Neuropathy

Typical optic neuritis and ONTT NMOSD and MOGAD Arteritic optic neuropathy and GCA NAION and ischaemic neuropathy comparison

36 Chapter 36: Papilloedema, IIH and Afferent Localisation

Papilloedema recognition and Frisén grading IIH diagnosis and vision protection Disc drusen and pseudopapilloedema Afferent pathways and chiasmal localization

37 Chapter 37: Congenital, Inherited and Cortical Neuro-Ophthalmology

Cortical vision and higher visual syndromes Neuro-ophthalmic testing and congenital optic discs Inherited, compressive, infiltrative and nutritional optic neuropathies Transient visual loss, headache and neurological emergencies

38 Chapter 38: Central Motor Control and Cranial Nerve Palsies

Central ocular motor control and supranuclear disorders Third- and fourth-nerve palsies Sixth nerve, pontine gaze and cavernous sinus

39 Chapter 39: Myasthenia and Ocular Myopathy

Myasthenic ocular weakness Myasthenia testing and treatment Myopathy, CPEO and Kearns–Sayre syndrome

40 Chapter 40: Pupillary Pathways and Anisocoria

Pupillary pathways and afferent defects Horner syndrome and tonic pupil Light–near dissociation and pupil differentials

41 Chapter 41: Orbit, Thyroid Eye Disease and Ptosis Assessment

Orbital anatomy and thyroid eye disease Orbital infection and idiopathic inflammation Orbital masses, approaches and eye-removal procedures Lid anatomy and ptosis evaluation

42 Chapter 42: Lid Repair and Lacrimal Drainage

Ptosis repair, malposition and eyelid tumours Lash disorders, facial palsy and lid reconstruction Lacrimal drainage and epiphora testing Nasolacrimal obstruction, infection and DCR

43 Chapter 43: Lacrimal Gland Disease, Pathology and Intraocular Tumours

Lacrimal gland inflammation and tumours Ocular histology, specimen handling and special stains Immunophenotyping, molecular pathology and tumour genetics Uveal melanoma and retinoblastoma

44 Chapter 44: Lymphoma, Surface Tumours and Paraneoplastic Disease

Vitreoretinal lymphoma Surface tumours, uveal metastases and benign mimics Paraneoplastic retinopathy, treatment effects and counselling

45 Chapter 45: Ocular Trauma and Vascular Systemic Disease

Trauma terminology and prognostic scoring Chemical injury and surface preservation Open-globe emergency management Vascular, endocrine, pregnancy and renal eye disease

46 Chapter 46: Multisystem Disease and Ophthalmic Pharmacology

Immune, metabolic and multisystem ocular clues Phakomatoses and syndrome-specific surveillance Connective-tissue and metabolic ocular disease Drug delivery and systemic glaucoma effects

47 Chapter 47: Medication Toxicity, Professional Practice and Clinical Stations

Retinal and optic medication toxicity Prevention, consent and professional practice Directed clinical answers and station rehearsal

Postoperative inflammation, haemorrhage and PCO

Key Takeaways Explain This Topic AI

TASS and infection can overlap in presentation, so timing and a clear vitreous alone cannot exclude infection.

Suprachoroidal haemorrhage requires stabilization and individualized assessment rather than a fixed drainage delay.

Before YAG treatment, confirm PCO explains the symptoms and consider retinal, pressure and implant risks.

Last updated: October 2026

  • Dropped Nucleus & Suprachoroidal Haemorrhage
  • The Dropped Nucleus Protocol

If a hard nuclear fragment drops through a capsular tear into the mid- or posterior vitreous cavity: NEVER chase the fragment into the vitreous with the phaco tip or vitrectomy cutter .

Blind posterior manipulation with non-vitreoretinal instruments causes giant retinal tears, rhegmatogenous retinal detachment, and catastrophic choroidal bleeding.

Management: Perform a meticulous bimanual anterior vitrectomy to ensure the anterior chamber and corneal incisions are completely free of vitreous. Implant a sulcus IOL if capsular rim support permits, or leave the eye aphakic. Suture all incisions securely with 10 − 0 10-0 10 − 0 nylon. Refer the patient urgently to a vitreoretinal surgeon for elective three-port 23 G / 25 G 23\text{G}/25\text{G} 23 G /25 G pars plana vitrectomy with phacofragmatome at timing determined by fragment size, inflammation, pressure, corneal clarity and retinal findings.

Acute Suprachoroidal Haemorrhage

Etiology: Rupture of a posterior or long ciliary artery into the suprachoroidal potential space between the choroid and sclera, driven by acute intraoperative hypotony in eyes with arteriosclerosis, systemic hypertension, advanced age, glaucoma, or high myopia.

Clinical Presentation: Sudden, rock-hard globe; abrupt shallowing of the anterior chamber; extrusion of the iris and intraocular contents through the wound; dark brown choroidal elevations visible in the pupil; and immediate loss of the red reflex.

Emergency Surgical Management:

Immediate Wound Closure: Abandon intraocular maneuvers instantly. Close all clear corneal and paracentesis incisions with pre-placed sutures or digital compression. Re-establishing intraocular pressure tamponades the bleeding artery.

Medical Tamponade: Administer IV mannitol ( 1.0 − 2.0 g/kg 1.0-2.0\text{ g/kg} 1.0 − 2.0 g/kg ), systemic antihypertensives, and high-dose intravenous/oral corticosteroids.

Further assessment and drainage: Close and stabilize the eye, then assess the extent with vitreoretinal input and ultrasound. Drainage may be timed to clot liquefaction, but apposition, pain, pressure, retinal involvement and the clinical course determine timing; a fixed 10–14-day delay is not mandatory in every threatened eye.

Toxic Anterior Segment Syndrome (TASS) vs Acute Postoperative Endophthalmitis

Distinguishing between sterile Toxic Anterior Segment Syndrome (TASS) and acute microbial endophthalmitis is one of the most critical clinical differentials in ophthalmology:

Diagnostic Feature Toxic Anterior Segment Syndrome (TASS) Acute Infectious Endophthalmitis

Onset of Presentation Hyperacute: 12 to 24 hours postoperatively (rarely up to 48 hours). Subacute / Delayed: 3 to 7 days postoperatively (median day 4–5).

Etiological Mechanism Sterile, non-infectious toxic/chemical insult to anterior segment structures. True intraocular microbial replication and active bacterial proliferation.

Common Causative Agents Bacterial endotoxins in autoclave steam; enzymatic detergent residues on cannulas; denatured OVD; intraocular preservatives (BAK); chlorhexidine; non-isotonic BSS. Staphylococcus epidermidis (coagulase-negative, ∼ 70 % \sim 70\% ∼ 70% ); Staphylococcus aureus ( ∼ 10 % \sim 10\% ∼ 10% ); Streptococcus species ( ∼ 10 % \sim 10\% ∼ 10% ); Gram-negative bacilli ( Pseudomonas , ∼ 5 % \sim 5\% ∼ 5% ).

Ocular Pain Mild discomfort or completely painless. Severe, deep, throbbing, unrelenting pain (marked in > 75 % >75\% > 75% of patients).

Corneal Findings Diffuse, limbus-to-limbus corneal oedema (widespread toxic endothelial necrosis). Focal wound oedema; central cornea frequently remains clear early in disease.

Anterior Chamber Heavy fibrinous reaction, large hypopyon, trabecular outflow shutdown with elevated IOP. Heavy fibrinous exudate, hypopyon, marked cellular reaction.

Pupil / Iris Fixed, dilated, or irregular pupil; iris atrophy (toxic sphincter necrosis). Pupil reactive or sluggish; no primary pupillary paralysis.

Vitreous and red reflex Usually predominantly anterior inflammation without substantial vitritis; view may still be reduced by corneal oedema Vitritis often occurs, but early or atypical infection may not have a completely absent red reflex

Response to Therapy Dramatic, rapid resolution with intensive topical corticosteroids (e.g., prednisolone acetate 1 % 1\% 1% hourly). Progressive deterioration without intravitreal antibiotics; steroids alone worsen condition.

Acute Postoperative Endophthalmitis: Prevention and Initial Response

Use ocular-surface antisepsis with an appropriate povidone-iodine preparation and validated intracameral antibiotic prophylaxis according to local guidance. Allergy, concentration, contamination and dilution errors matter; prophylaxis must not replace aseptic technique.

Suspected infection requires urgent vitreoretinal assessment, sampling and intravitreal antibiotics. Common empiric coverage is vancomycin 1 mg/0.1 mL plus ceftazidime 2.25 mg/0.1 mL using separately prepared validated syringes. Confirm allergy and local protocol; intravitreal steroid adjuncts have uncertain benefit.

The 1995 Endophthalmitis Vitrectomy Study (EVS) involved acute postoperative infection after cataract or secondary-IOL surgery. Immediate vitrectomy improved outcomes in its light-perception-only subgroup, while tap/inject and vitrectomy had similar outcomes for better initial acuity. Modern surgical systems and different infections require individual decisions: hand-motions acuity does not preclude vitrectomy, and the study cannot be applied unchanged to traumatic, endogenous or fungal disease. Treatment is urgent and cannot await cultures.

TASS and infection overlap in onset, pain and inflammatory signs. A clear vitreous with early diffuse corneal oedema supports TASS, but uncertainty requires assessment and treatment for possible infection rather than an unobserved steroid trial.

Posterior Capsule Opacification (PCO) & Nd:YAG Laser Capsulotomy

Posterior capsule opacification is the most common delayed complication of modern cataract surgery, developing in 20 to 40 % 20\text{ to }40\% 20 to 40% of eyes within 2 to 5 years.

Pathogenesis & Morphological Forms

Residual equatorial lens epithelial cells (LECs) survive surgical aspiration, proliferate, migrate across the posterior capsule, and undergo epithelial-mesenchymal transition (EMT):

Regeneratory / Pearl-Type PCO: Proliferating epithelial cells swell into large, clusters of globular, nucleated cells: Elschnig pearls (histologically identical to Wedl cells). This is the most common form, causing gradual reduction in visual acuity, contrast sensitivity, and photopic glare.

Fibrotic PCO: Myofibroblastic transdifferentiation produces alpha-smooth muscle actin ( α \alpha α -SMA), causing capsular wrinkling, contracture, dense fibrosis, and star-shaped folds along the visual axis.

Preventive Surgical Factors

Square-Edge Optic Geometry: A sharp, 90 ∘ 90^\circ 9 0 ∘ posterior optic edge acts as a mechanical barrier that arrests migrating lens epithelial cells.

Complete 360 ∘ 360^\circ 36 0 ∘ Capsulorhexis Overlap: Ensuring the anterior rhexis leaf completely overlaps the 6.0 mm 6.0\text{ mm} 6.0 mm optic creates an anatomical shrink-wrap seal.

IOL Material: Hydrophobic acrylic polymers bind fibronectin tightly, establishing superior capsular adhesion and lower PCO rates than hydrophilic acrylic or PMMA.

Nd:YAG Laser Capsulotomy Technique & Complications

Laser Physics: Neodymium-doped Yttrium Aluminum Garnet (Nd:YAG) pulsed laser ( λ = 1064 nm \lambda = 1064\text{ nm} λ = 1064 nm , infrared). Operates by optical breakdown and photodisruption: intense localized electrical field ionizes tissue into plasma, producing acoustic shock waves that cut the non-pigmented capsule.

Technique: Use the device-specific focusing offset and the lowest effective pulse energy. Place an opening appropriate to visual symptoms, pupil size and IOL position while avoiding optic pitting. Energy, offset and aperture diameter are adjustable clinical choices, not fixed settings for every eye.

Complications:

Transient IOP Spike: Peaks at 1 to 4 hours post-laser due to trabecular meshwork clogging by capsular debris and inflammatory cells. Prophylaxis: topical apraclonidine 1 % 1\% 1% or brimonidine 0.2 % 0.2\% 0.2% before and after the procedure.

IOL Pitting / Damage: Optical divots created if the laser is focused directly on the IOL material.

Macular oedema: Investigate reduced vision with examination and OCT; risk depends on inflammation and retinal comorbidity.

Retinal tears/detachment: Counsel about new flashes, floaters and a curtain, especially with myopia or previous retinal disease. A fixed percentage increase does not apply to every capsulotomy.